(Q44334503)

2 December 2017

title

Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone (English)

1 reference

2 December 2017

0 references

C E Rosow

1

1 reference

2 December 2017

P Gomery

2

1 reference

2 December 2017

T Y Chen

3

1 reference

2 December 2017

P Stefanovich

4

1 reference

2 December 2017

N Stambler

5

1 reference

2 December 2017

R Israel

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

28 March 2007

1 reference

Clinical Pharmacology & Therapeutics

2 December 2017

published in

1 reference

2 December 2017

volume

82

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

48-53

1 reference

The central and peripheral influences of opioids on gastrointestinal propulsion

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Postoperative urinary retention. I. Incidence and predisposing factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Central and peripheral motor effects of morphine on the rat urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Morphine and the centrally-mediated inhibition of urinary bladder motility in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Intrathecal opioids and lower urinary tract function: a urodynamic evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Opioid-induced delay in gastric emptying: a peripheral mechanism in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Urinary bladder contraction and relaxation: physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

In vivo motor effects of loperamide on the rat urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Enkephalinergic inhibition in parasympathetic ganglia of the urinary bladder of the cat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Rho kinase: a target for treating urinary bladder dysfunction?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100164

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100164

1 reference

2 December 2017

1 reference